Sheba Medical Center
Clinical trials sponsored by Sheba Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood cell energy study could predict ketamine response in depression Results expected Sep 2026 (estimated)
- Simple arm position change could improve blood pressure checks in pregnancy Results expected Sep 2026 (estimated)
- No-Needle patch could protect your smile during surgery Results expected Feb 2027 (estimated)
- Aging on pause? new study tests personalized plans to turn back your biological clock. Results expected Mar 2027 (estimated)
- Spit test may reveal clues about rare muscle disease Results expected Mar 2027 (estimated)
-
Alga supplement could boost sight in rare eye disease
Disease control By invitation onlyThis study tests whether a natural supplement from Dunaliella alga, rich in 9-cis beta-carotene, can improve vision in adults with retinitis pigmentosa. Forty-one participants will take the supplement or a placebo for 3 months, then switch after a 6-month break. Researchers will …
Phase 1/2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could an allergy drug boost brain function in williams syndrome?
Disease control OngoingThis phase 2 trial tests whether clemastine, a common allergy medication, can improve thinking, motor skills, and social abilities in people with Williams syndrome. The study includes 30 participants aged 6 to 30 and uses a double-blind, placebo-controlled design to measure safet…
Phase 2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC